A legal bid by fish health products provider STIM to ban the sale of feed producer BioMar’s Intro Tuning has been denied. The Norwegian courts have found that BioMar’s smoltification feed does not infringe STIM’s patent for its SuperSmolt system and the production and sale will continue as normal.

Fears that lighter coloured and translucent sea lice may be harder to count and less vulnerable to cleaner fish have proved unfounded, according to fish health companies in Norway.

Pharma and nutrition company STIM (formerly Europharma) has won a double victory in its fight to protect its patented SuperSmolt technology.

Feed manufacturer BioMar is to appeal a Norwegian court decision that it infringed a patent held by pharma and nutrition company STIM (formerly Europharma) for its SuperSmolt technology that improves consistency of smoltification under constant light.

A Norwegian court has ordered feed producer BioMar to pay millions of kroner in compensation to STIM (formerly Europharma) for patent infringement and breach of good business practice.